Early genomic investigation (eg, genome, exome, lysosomal storage disorder genes, or MAN2B1 sequencing) and biochemical diagnostics are recommended for patients with learning disability and hearing impairment to reduce diagnostic delays for alpha-mannosidosis. Here, MAN2B1 is linked to alpha-mannosidosis.